measuregroup/AID197654

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103223830_AID197654_PMID3040999_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID160677203_AID197654_PMID3040999_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103224172_AID197654_PMID3040999_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103223831_AID197654_PMID3040999_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103469419_AID197654_PMID3040999_VALUE4
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22199
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Relative anti-mineralocorticoid potency compared to Spironolactone after oral administration
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103223830 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103223831 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID160677203 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103469419 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103224172
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID197654

Total number of triples: 15.